Paper32101660
Escaping Pandora's Box - Another Novel Coronavirus.
Morens DM and 2 others. N Engl J Med, 2020. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. Escaping Pandora's Box - Another Novel Coronavirus. Papers, record 32101660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32101660
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Betacoronavirus | Major topic |
| Chiroptera | Major topic |
| Coronavirus Infections | Major topic |
| Pandemics | Major topic |
| Pneumonia, Viral | Major topic |
| Zoonoses | Major topic |
| Animals | |
| COVID-19 | |
| History, 19th Century | |
| History, 20th Century | |
| Humans | |
| Influenza Pandemic, 1918-1919 | |
| Middle East Respiratory Syndrome Coronavirus | |
| Severe acute respiratory syndrome-related coronavirus | |
| SARS-CoV-2 | |
| Severe Acute Respiratory Syndrome | |
| Virus Diseases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIAAI001271 | NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04558125 | Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism | Background |
Source ClinicalTrials.gov
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42361016 | Gendered male and high-income country authors dominate publication at a One Health research organization. | PLoS One | 2026 | https://conductscience.org/library/papers/42361016 | PubMed |
| 42053295 | Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment. | J Virol | 2026 | https://conductscience.org/library/papers/42053295 | PubMed |
| 41398910 | Development and evaluation of a novel nebulized dihydromyricetin formulation: enhanced pulmonary delivery and pharmacokinetic properties. | Respir Res | 2025 | https://conductscience.org/library/papers/41398910 | PubMed |
| 40741277 | Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/40741277 | PubMed |
| 40720505 | Early pandemic associations of latitude, sunshine duration, and vitamin D status with COVID-19 incidence and fatalities: A global analysis of 187 Countries. | PLOS Glob Public Health | 2025 | https://conductscience.org/library/papers/40720505 | PubMed |
| 39247005 | Did the Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Breast Cancer Patients? | Cureus | 2024 | https://conductscience.org/library/papers/39247005 | PubMed |
| 38171875 | An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature. | Intern Med | 2024 | https://conductscience.org/library/papers/38171875 | PubMed |
| 37448935 | Revitalizing primary care is the key to people's health in the post-COVID era. | J Family Med Prim Care | 2023 | https://conductscience.org/library/papers/37448935 | PubMed |
| 37196023 | Monitoring and responding to emerging infectious diseases in a university setting: A case study using COVID-19. | PLoS One | 2023 | https://conductscience.org/library/papers/37196023 | PubMed |
| 37140873 | Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study. | Intern Emerg Med | 2023 | https://conductscience.org/library/papers/37140873 | PubMed |
| 36992209 | Epidemiology of the Acceptance of Anti COVID-19 Vaccine in Urban and Rural Settings in Cameroon. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36992209 | PubMed |
| 36936870 | Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease. | J Clin Biochem Nutr | 2023 | https://conductscience.org/library/papers/36936870 | PubMed |
| 36817436 | Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease. | Front Immunol | 2023 | https://conductscience.org/library/papers/36817436 | PubMed |
| 36417106 | An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine. | Clin J Gastroenterol | 2023 | https://conductscience.org/library/papers/36417106 | PubMed |
| 36378059 | Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial. | J Tradit Chin Med | 2022 | https://conductscience.org/library/papers/36378059 | PubMed |
| 36267993 | Trends of myopia development among primary and junior school students in the post-COVID-19 epidemic period. | Front Public Health | 2022 | https://conductscience.org/library/papers/36267993 | PubMed |
| 36215506 | Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36215506 | PubMed |
| 36142955 | Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/36142955 | PubMed |
| 35960372 | The 'welcomed lockdown' hypothesis? Mental wellbeing and mobility restrictions. | Eur J Health Econ | 2023 | https://conductscience.org/library/papers/35960372 | PubMed |
| 35948797 | Multi-region machine learning-based novel ensemble approaches for predicting COVID-19 pandemic in Africa. | Environ Sci Pollut Res Int | 2023 | https://conductscience.org/library/papers/35948797 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32101660
GET https://conductscience.org/api/papers/v1/32101660/cited_by?page=2